Barriers to new drug development in respiratory disease.
Airways Disease Section, National Heart and Lung Institute, Imperial College London, London, UK p.j.barnes@imperial.ac.uk.
Peter J
PJ
Barnes
Second University of Naples, Caserta, Italy Institute of Translational Pharmacology-CNR, Rome, Italy European Medicines Agency, London, UK.
Sergio
S
Bonini
University of Giessen and Marburg Lung Centre, Member of the German Centre for Lung Research (DZL), Giessen, Germany.
Werner
W
Seeger
Airways Disease Section, National Heart and Lung Institute, Imperial College London, London, UK.
Maria G
MG
Belvisi
European Affairs Dept, European Respiratory Society, Brussels, Belgium.
Brian
B
Ward
National Centre for the Replacement, Refinement and Reduction of Animals in Research (NC3Rs), London, UK.
Anthony
A
Holmes
D000818:Animals; D001249:Asthma / Q000188:drug therapy; D004195:Disease Models, Animal; D055808:Drug Discovery; D004353:Drug Evaluation, Preclinical; D004345:Drug Industry / Q000331:legislation & jurisprudence / Q000639:trends*; D005858:Germany; D006801:Humans; D007558:Italy; D029424:Pulmonary Disease, Chronic Obstructive / Q000188:drug therapy; D012120:Respiration Disorders / Q000188:drug therapy*; D019141:Respiratory System Agents / Q000494:pharmacology*
D019141:Respiratory System Agents